Navigation Links
Women often opt to surgically remove their breasts, ovaries to reduce cancer risk
Date:8/5/2009

PHILADELPHIA Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

"Women have their breasts or ovaries removed based on their risk. It does not always happen immediately after counseling or a genetic test result and can take more than seven years for patients to decide to go forward with surgery," said lead researcher D. Gareth Evans, M.D. Evans is a consultant in clinical genetics at the Genesis Prevention Center, University Hospital of South Manchester NHS Trust and a professor at the University of Manchester, United Kingdom.

Evans and colleagues assessed the increase in risk-reduction surgery among women with breast cancer and evaluated the impact of cancer risk, timing and age.

Rate of increase was measured among 211 women with known unaffected BRCA1 or BRCA2 mutation carriers. BRCA1 and BRCA2 are hereditary gene mutations that indicate an increased risk for developing breast cancer. Additionally, more than 3,500 women at greater than 25 percent lifetime risk of breast cancer without mutations also had a documented increase in risk-reduction surgery.

Women who had a biopsy after undergoing risk evaluation were twice as likely to choose a risk-reducing mastectomy. Forty percent of the women who were mutation carriers underwent bilateral risk-reducing mastectomy; 45 percent had bilateral risk-reducing salpingo-oophorectomy (surgical removal of ovaries). These surgeries are widely used by carriers of BRCA1 and BRCA2 gene mutations to reduce the risk for breast and ovarian cancer.

Evaluated by gene type, bilateral risk-reducing salpingo-oophorectomy was more common in women who were BRCA1 gene carriers 52 percent had the surgery compared with 28 percent of the women who were BRCA2 gene car
'/>"/>

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Health benefits of physical activity more pronounced in women
2. UTMB study identifies women at risk of gaining excessive weight with injectable birth control
3. Study explains potential failure of oral contraceptives with obese women
4. Fruit and vegetable intake in pregnant women reduces risk of upper respiratory tract infection
5. Two dietary oils, two sets of benefits for older women with diabetes
6. Women with endometriosis need special care during pregnancy to avoid risk of premature birth
7. New MRI technique could mean fewer breast biopsies in high-risk women
8. New, less invasive genetic test greatly improves pregnancy rates in older women with poor prognosis
9. Debate on admin. of magnesium sulfate to pregnant women to prevent cerebral palsy in pre-term infants
10. Following the dietary guidelines may slow heart disease in women
11. Single women gaze longer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... (January 28, 2013)A popular dog treat could be adding ... contaminated by bacteria, according to a study published this ... Medicine at Tufts University and the University of Guelph. ... stick." The American and Canadian researchers analyzed the caloric ...
... CORVALLIS, Ore. Dairy cows that are fed flaxseed produce ... State University. Their milk contained more omega-3 fatty acids ... in saturated fat can increase cholesterol and cause heart disease, ... may reduce the risk of heart disease, studies have shown. ...
... in German . , The detector ... has a very low error rate. The results have ... Ultrafast, efficient, and reliable single-photon detectors are among the ... have not yet reached maturity for practical application. Physicist ...
Cached Biology News:Misconceptions about a popular pet treat 2Misconceptions about a popular pet treat 3Cows fed flaxseed produce more nutritious dairy products 2Quantum communication: Each photon counts 2
(Date:12/13/2014)... The “Global Synthetic Biology Market ... threats, opportunities, and challenges. , The global synthetic ... namely, Thermo Fisher Scientific, Inc. (U.S.), DuPont (U.S.), ... accounted for approximately ~65% of the total synthetic ... for This Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html , ...
(Date:12/13/2014)... , Dec. 12, 2014  Vermillion, Inc. (NasdaqCM: VRML), a ... the appointments of Veronica G. H. Jordan , ... Company,s Board of Directors, bringing the total number of ... Jim LaFrance , Chairman, President, and ... pleased to announce the appointments of Veronica and David ...
(Date:12/13/2014)... RARITAN, N.J. and SAN ANTONIO ... Development, LLC (Janssen) today announced the presentation of data ... the Phase 3 EPO-ANE-3010 study evaluating epoetin alfa plus ... treat anemia in patients with metastatic breast cancer receiving ... primary objective, which was to rule out a 15 ...
(Date:12/12/2014)... Pittsburgh, PA (PRWEB) December 11, 2014 ... 2015 Technical Program that includes over 2,000 ... awards, and posters. This year’s program covers ... not limited to, biotechnology, biomedical, drug discovery, environmental, ... nanotechnology, polymers/plastics, proteomics and water/wastewater. The Technical ...
Breaking Biology Technology:Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 2Pittcon Announces a Diverse 2015 Technical Program - Renowned Speakers, Special Symposia and Co-programming 3
... Company Purchases Two PCT Systems to Help in the Analysis of ... SOUTH EASTON, Mass., Dec. 17 Pressure BioSciences, Inc. ... entered into a collaboration with the J. Craig Venter Institute ("JCVI"), ... MD and La Jolla, CA. As part of the collaboration, ...
... recent customer satisfaction,survey of over 30,000 readers of ADVANCE ... customers as the "Top Of Class" winner for the,microbiology ... ADVANCE chose bioMerieux over other clinical laboratory suppliers,because of ... "quick response time." , ...
... scheduled 16-17 February in Kuala Lumpur, Malaysia, an ... makers have been scheduled. Kicking off the series, ... Pradip Bhar, Chief Executive Officer and Managing Director ... download, this informative interview lends startling insights into ...
Cached Biology Technology:Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System 2Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System 3Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System 4Pressure BioSciences, Inc. and the J. Craig Venter Institute Announce Collaboration Agreement & Purchase of a PCT System 5Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 3Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 4
...
... Characteristics:, Antibody Binding: High, 400 ng ... volume) , Binding Interaction: Hydrophobic/Ionic , Performance ... (bottom): Flat , Maximum Well Volume: 360 ... tray ,Features, Special optically clear ...
...
...
Biology Products: